Assessing of effect of nifedipine on IVF
Phase 2
Recruiting
- Conditions
- Infertility.Female infertility
- Registration Number
- IRCT20210227050515N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Having a frozen embryo and a candidate for embryo transfer
Patients who are candidates for infertility treatment other than in vitro fertilization
Exclusion Criteria
Patients who are candidates for infertility treatment other than in vitro fertilization
BMI>38
Contraindications to the use of nifedipine and estrogen or progesterone
Patients treated with other drugs that interfere with nifedipine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Beta HCG test positive rate after IVF. Timepoint: Two weeks after IVF. Method of measurement: Beta HCG test.
- Secondary Outcome Measures
Name Time Method